Methyl ethylpyridinol-Eskom - instructions for use, dose, side effects, contraindications

It has retinoprotective properties, protects the retina from the damaging effect of high-intensity light, promotes resorption of intraocular hemorrhages, improves microcirculation of the eye.

Reduces the permeability of the vascular wall, is an inhibitor of free radical processes, antihypoxant and antioxidant, reduces blood viscosity and platelet aggregation.

Pharmacokinetics:Data on the pharmacokinetics of the drug are absent.

Indications:In the complex therapy: subconjunctival and intraocular hemorrhage; angioretinopathy (including diabetic); chorioretinal dystrophy (including atherosclerotic origin); dystrophic keratitis; vascular thrombosis of the retina; complications of myopia; protection of the cornea (when wearing contact lenses) and the retina of the eye from exposurelight of high intensity (laser and sunburn, with laserocoagulation); trauma, inflammation and burn of the cornea; cataracts (including prevention in persons older than 40 years); surgical interventions on the eyes; condition after surgery for glaucoma with detachment of the choroid.

Contraindications:Hypersensitivity, pregnancy, lactation, children under 18 years.

Carefully:Be wary appoint patients with allergic reactions in the history.

Dosing and Administration:

Subconjunctival or parabulbar - once a day or every other day. Subconjunctival - 0.2-0.5 ml of 1% solution (2-5 mg), parabulbar - 0.5-1 ml of 1% solution (5-1 mg). Duration of treatment - 10-30 days; it is possible to repeat the course 2-3 times a year.

Retrobulbarno for 0.5-1 ml of a 1% solution once a day for 10-15 days.

To protect the retina in lacerocoagulation (including with limiting and destructive coagulation of tumors) - parabulbar or retrobulbno for 0.5-1 ml of 1% solution for 24 hours and 1 hour before coagulation; then 0.5-1 ml of a 1% solution once a day for 2-10 days.

Side effects:

When used in ophthalmology with the introduction of methylethylpyridinol, pain, burning sensation, itching, redness, and also sealing of parorbital tissues, which dissolves independently, are possible.

Short-term excitation, drowsiness, increased blood pressure, allergic reactions (skin rashes, etc.).

Overdose:Data on drug overdose are absent.

Interaction:A solution of methyl ethyl pyridinol should not be mixed with solutions of other drugs (pharmaceutically incompatible with other drugs).

Special instructions:Treatment should be carried out under the control of blood pressure and blood coagulability.

Form release / dosage:Solution for injection 10 mg / ml.

Packaging:

1 ml per ampoule of light-protective neutral glass or neutral glass with a fracture ring or a notch.

5 or 10 ampoules are placed in a contour mesh package made of a polyvinyl chloride film.

For 1 or 2 outline carton packs, together with the instructions for use are placed in a cardboard box.

Storage conditions:In the dark place at a temperature of no higher than 25 ° C. Do not freeze. Keep out of the reach of children.

Shelf life:3 years. Do not use after the expiration date printed on the package.

Terms of leave from pharmacies:On prescription

Registration number:LSR-007041/09

Date of registration:07.09.2009

Expiration Date:Unlimited

The owner of the registration certificate:ESKOM NPK, OAO ESKOM NPK, OAO Russia

Manufacturer: & nbsp

ESKOM NPK, OAO Russia

Information update date: & nbsp08.05.2018

Illustrated instructions

Instructions

Methyl ethylpyridinol-Eskom (Methylethylpiridinol-Eskom)